Rationale and design of a cluster-randomized multifaceted intervention trial to improve stroke care quality in China: The GOLDEN BRIDGE-Acute Ischemic Stroke

American Heart Journal

Volumn 169, Issue 6, 2015, Pages 767-774.e2

  Wang, Yilong ^a   Li, Zixiao ^a   Xian, Ying ^b   Zhao, Xingquan ^a   Li, Hao ^a   Shen, Haipeng ^c   Wang, Chunxue ^a   Liu, Liping ^a,c   Wang, Chunjuan ^a,d   Pan, Yuesong ^a,e   Wang, David ^f   Prvu Bettger, Janet ^b,g   Fonarow, Gregg C ^g   Schwamm, Lee H ^h   Smith, Sidney C ⁱ   Peterson, Eric D ^b   Wang, Yongjun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c The University of North Carolina at Chapel Hill   (United States)

^d BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

^e UNIVERSITY OF ILLINOIS   (United States)

^f DUKE UNIVERSITY   (United States)

^g UCLA MEDICAL CENTER   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHINA; CLINICAL PATHWAY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; HEALTH CARE QUALITY; HUMAN; INFORMATION PROCESSING; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN; CLINICAL PROTOCOL; CLINICAL TRIAL; HOSPITAL; ORGANIZATION AND MANAGEMENT; PATIENT CARE; STANDARDS; STROKE; TOTAL QUALITY MANAGEMENT;

BRAIN ISCHEMIA; CHINA; CLINICAL PROTOCOLS; CRITICAL PATHWAYS; HOSPITALS; HUMANS; PATIENT CARE TEAM; QUALITY IMPROVEMENT; STROKE;

EID: 84930147049     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.03.008     Document Type: Article

References (34)

1. G. Yang, Y. Wang, and Y. Zeng Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010 Lancet 381 2013 1987 2015
2. M. Liu, B. Wu, and W.Z. Wang Stroke in China: epidemiology, prevention, and management strategies Lancet Neurol 6 2007 456 464
3. Z.C. The third national survey on the cause of death. Ministry of Health 2008 Peking Union Medical University Press People's Republic of China
4. Stroke prevention: the need for a global response Lancet Neurol 10 2011 1
5. S.M. Davis, and G.A. Donnan Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack N Engl J Med 366 2012 1914 1922
6. Y. Wang, Y. Wang, and X. Zhao Clopidogrel with aspirin in acute minor stroke or transient ischemic attack N Engl J Med 369 2013 11 19
7. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group Lancet 349 1997 1569 1581
8. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group Lancet 349 1997 1641 1649
9. Collaboration C.T. M. Dennis, and P.A. Sandercock Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial Lancet 373 2009 1958 1965
10. D.G. Sherman, G.W. Albers, and C. Bladin The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison Lancet 369 2007 1347 1355
11. C. Mazzone, G.F. Chiodo, and P. Sandercock Physical methods for preventing deep vein thrombosis in stroke Cochrane Database Syst Rev 2004 CD001922
12. M.K. Gould, A.D. Dembitzer, and R.L. Doyle Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials Ann Intern Med 130 1999 800 809
13. D.J. Ramsey, D.G. Smithard, and L. Kalra Early assessments of dysphagia and aspiration risk in acute stroke patients Stroke 34 2003 1252 1257
14. L. Perry, and C.P. Love Screening for dysphagia and aspiration in acute stroke: a systematic review Dysphagia 16 2001 7 18
15. K.R. Lees, E. Bluhmki, and R. von Kummer Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials Lancet 375 2010 1695 1703
16. P. Amarenco, J. Bogousslavsky, and A. Callahan High-dose atorvastatin after stroke or transient ischemic attack N Engl J Med 355 2006 549 559
17. W.J. Wang, J.J. Lu, and Y.J. Wang Clinical characteristics, management, and functional outcomes in Chinese patients within the first year after intracerebral hemorrhage: analysis from China National Stroke Registry CNS Neurosci Ther 18 2012 773 780
18. Y. Wang, X. Liao, and X. Zhao Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR) Stroke 42 2011 1658 1664
19. Y.X. Deng, Y.L. Wang, and B.Q. Gao Age differences in clinical characteristics, health care, and outcomes after ischemic stroke in China CNS Neurosci Ther 18 2012 819 826
20. S.C. Johnston, S. Sidney, and N.K. Hills Standardized discharge orders after stroke: results of the quality improvement in stroke prevention (QUISP) cluster randomized trial Ann Neurol 67 2010 579 589
21. California Acute Stroke Pilot Registry I The impact of standardized stroke orders on adherence to best practices Neurology 65 2005 360 365
22. A. De Luca, D. Toni, and L. Lauria An emergency clinical pathway for stroke patients - results of a cluster randomised trial (isrctn41456865) BMC Health Serv Res 9 2009 14
23. J.M. Grimshaw, L. Shirran, and R. Thomas Changing provider behavior: an overview of systematic reviews of interventions Med Care 39 2001 II2 II45
24. O. Berwanger, H.P. Guimaraes, and L.N. Laranjeira Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial JAMA 307 2012 2041 2049
25. M.K. Campbell, G. Piaggio, and D.R. Elbourne Consort 2010 statement: extension to cluster randomised trials BMJ 345 2012 e5661
26. W.J. Taylor, A. Wong, and R.J. Siegert Effectiveness of a clinical pathway for acute stroke care in a district general hospital: an audit BMC Health Serv Res 6 2006 16
27. E.C. Jauch, J.L. Saver, and H.P. Adams Jr. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 44 2013 870 947
28. G.C. Fonarow, M.J. Reeves, and E.E. Smith Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in Get With The Guidelines-Stroke Circ Cardiovasc Qual Outcomes 3 2010 291 302
29. S.J. Edwards, D.A. Braunholtz, and R.J. Lilford Ethical issues in the design and conduct of cluster randomised controlled trials BMJ 318 1999 1407 1409
30. Centers for Disease C, Prevention Use of a registry to improve acute stroke care - seven states, 2005-2009 MMWR Morb Mortal Wkly Rep 60 2011 206 210
31. K. Huang, N. Khan, and A. Kwan Socioeconomic status and care after stroke: results from the Registry of the Canadian Stroke Network Stroke 44 2013 477 482
32. Y. Hong, and K.A. LaBresh Overview of the American Heart Association "Get With The Guidelines" programs: coronary heart disease, stroke, and heart failure Crit Pathw Cardiol 5 2006 179 186
33. L.H. Schwamm, G.C. Fonarow, and M.J. Reeves Get With The Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack Circulation 119 2009 107 115
34. A.G. Ellrodt, G.C. Fonarow, and L.H. Schwamm Synthesizing lessons learned from Get With The Guidelines: the value of disease-based registries in improving quality and outcomes Circulation 128 2013 2447 2460